BSEMNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
BioStem Technologies, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$1.54−0.55 (-26.32%)
Close on Oct 19, 2026
- Market cap
- $26.68M
- P/E (TTM)
- –
- Dividend yield
- –
About BioStem Technologies
Biological Products, (No Diagnostic Substances), SIC 2836
BioStem Technologies, Inc. is listed on Nasdaq under the ticker BSEM, in the SEC industry Biological Products, (No Diagnostic Substances). It is incorporated in Florida and its fiscal year ends on December 31. Reported financials on StockData start in fiscal 2024.
Company profile
Company
- Legal name
- BioStem Technologies, Inc.
- Headquarters
- Pompano Beach, FL
- Address
- 2836 Center Port Circle 33604
- Phone
- (954) 380-8342
- Website
- biostemtechnologies.com
- Industry
- Biological Products, (No Diagnostic Substances)
- Incorporated in
- Florida
- Fiscal year ends
- December 31
Stock & identifiers
- Ticker
- BSEM
- Exchange
- Nasdaq
- IPO date
- Mar 17, 2015
- Shares outstanding
- 18M, Aug 12, 2026
- Filer category
- Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
- SEC CIK
- 1658678
- EIN
- 27-0400416
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Vurst Andrew Smith-Van | Chief Operating Officer, Director | 1,539,809 |
| Jason Matuszewski | Chief Executive Officer, Director | 1,303,552 |
| Brandon Poe | Chief Financial Officer | 58,062 |
| Michael A. Fortunato | Chief Accounting Officer | 68,664 |
| Barry Hassett | Chief Commercial Officer | 5,003 |
| Katherine Gorrell | CLCO | – |
| Kenneth Howard Warrington Jr | Director | 33,928 |
| Mark A. Glickman | Director | 7,671 |
| Hannaway Rayna Lesser | Director | 7,671 |
| Jodi Ungrodt | Director | 11,295 |
| Steven D. Sonenreich | Director | 7,671 |
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Oct 28, 2025 | Name change | Name changed from BIOSTEM TECHNOLOGIES to BioStem Technologies, Inc. |
| Sep 27, 2024 | Spin-off | Registration as a new public company (Form 10), e.g. spin-off |